Agomab Therapeutics (AGMB) said late Monday it closed its initial public offering of 12.5 million American depository shares at a public offering price of $16 per ADS, raising about $200 million in gross proceeds before underwriting fees and expenses.
The American depository shares started trading on the Nasdaq Global Select Market on Feb. 6.